Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scolari, F.
Right arrow Articles by Maiorca, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scolari, F.
Right arrow Articles by Maiorca, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 10 2536-2546, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Autosomal dominant medullary cystic disease: a disorder with variable clinical pictures and exclusion of linkage with the NPH1 locus

F Scolari, G Ghiggeri, G Casari, A Amoroso, D Puzzer, G Caridi, B Valzorio, R Tardanico, V Vizzardi, S Savoldi, B Viola, N Bossini, E Prati, R Gusmano and R Maiorca
Division and Chair of Nephrology, Spedali Civili and University, Piazza Spedali Civili 1, I-25125 Brescia, Italy; Division of Paediatric Nephrology, G. Gaslini Childrens Hospital, Genova, Italy; Telethon Institute of Genetics and Medicine (TIGEM), S. Raffaele Biomedical Science Park, Spedali Civili, Brescia, Italy; Dialysis Service, Desenzano, Italy; Corresponding author

Background. The nephronophthisis-medullary cystic disease (NPH/MCD) complex represents a heterogeneous group of hereditary tubulointerstitial nephritis. The most common variant is juvenile recessive NPH, for which a gene locus (NPH1) has been mapped on chromosome 2q13. MCD is a less common dominant condition usually recognized later in life, which resembles NPH in many aspects, still presenting remarkable clinical differences. Nothing is known about the chromosome locus of MCD. Methods. Five MCD families were studied. Diagnosis was made by inference from family history, type of inheritance, clinical signs and histology. Multipoint linkage analysis was performed by markers D2S293, D2S340 and D2S160 spanning the entire NPH1 locus. Results. Diagnosis of MCD was made in 28 affected members (16 males; 12 females), belonging to five families. Histological diagnosis was available in 10 patients; clinical diagnosis in 11; seven deceased relatives had diagnosis of chronic nephritis. The age at diagnosis ranged from 8 to 65 years. Renal medullary cysts were found in a minority of patients. In family 1, the disease was associated with hyperuricaemia and gouty arthritis. Progression of renal disease presented intra- and extra-family variability with members of the same family showing mild elevation of creatinine or terminal renal failure. The NPH1 locus associated to recessive NPH was excluded from linkage to the dominant MCD. Conclusions. MCD might be more common than previously assumed. Variability in clinical presentation and absence of histopathological hallmarks contribute to make the diagnosis uncommon. The most remarkable clinical difference with NPH is the age of onset in some kindreds and a delayed progression towards renal failure. The exclusion of linkage to the NPH1 locus suggests the existence of an MCD responsible locus, still to be mapped. Keywords: gout; hyperuricaemia; linkage analysis; medullary cystic disease; nephronophthisis; NPH1 locus
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
K. Dahan, O. Devuyst, M. Smaers, D. Vertommen, G. Loute, J.-M. Poux, B. Viron, C. Jacquot, M.-F. Gagnadoux, D. Chauveau, et al.
A Cluster of Mutations in the UMOD Gene Causes Familial Juvenile Hyperuricemic Nephropathy with Abnormal Expression of Uromodulin
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2883 - 2893.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. M. Stacey, J. J. O. Turner, B. Harding, M. A. Nesbit, P. Kotanko, K. Lhotta, J. G. Puig, R. J. Torres, and R. V. Thakker
Genetic Mapping Studies of Familial Juvenile Hyperuricemic Nephropathy on Chromosome 16p11-p13
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. DAHAN, A. FUCHSHUBER, S. ADAMIS, M. SMAERS, S. KROISS, G. LOUTE, J.-P. COSYNS, F. HILDEBRANDT, C. VERELLEN-DUMOULIN, and Y. PIRSON
Familial Juvenile Hyperuricemic Nephropathy and Autosomal Dominant Medullary Cystic Kidney Disease Type 2: Two Facets of the Same Disease?
J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2348 - 2357.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Kroiss, K. Huck, S. Berthold, F. Ruschendorf, F. Scolari, G. Caridi, G. M. Ghiggeri, F. Hildebrandt, and A. Fuchshuber
Evidence of further genetic heterogeneity in autosomal dominant medullary cystic kidney disease
Nephrol. Dial. Transplant., June 1, 2000; 15(6): 818 - 821.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.